Orthoplastics is a leading manufacturer of ultra-high molecular weight polyethylene (UHMWPE) products and components for the global orthopedic implant market. UHMWPE is the leading material technology used for acetabular cup linings in hip implant systems, and patella inserts and articulating surfaces in knee implant systems. As one of the major UHMWPE product suppliers to the strictly regulated orthopedic implant market, Orthoplastics’ products may be found in nearly half of the world’s hip and knee implants. The company’s advanced engineering and production capabilities have positioned it as a vital link in the global supply chain for next generation orthopedic devices. Orthoplastics is based in Bacup, UK, and was a portfolio company of Harwood Private Equity and other funds managed by Harwood Capital LLP. For more information on Orthoplastics, please visit www.orthoplastics.com.